These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 4503072

  • 1. The value of urine cytology in the diagnosis of recurrent bladder tumors. A preliminary report.
    reichborn-Kjennerud S, Hoeg K.
    Acta Cytol; 1972; 16(3):269-72. PubMed ID: 4503072
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A, Kumar R, Gupta NP.
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [Abstract] [Full Text] [Related]

  • 3. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C, Chautard D, Devonec M, Perrin P, Chopin D, Rischmann P, Bouchot O, Beurton D, Coulange C, Rambeaud JJ.
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [Abstract] [Full Text] [Related]

  • 4. Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings.
    Yoder BJ, Skacel M, Hedgepeth R, Babineau D, Ulchaker JC, Liou LS, Brainard JA, Biscotti CV, Jones JS, Tubbs RR.
    Am J Clin Pathol; 2007 Feb; 127(2):295-301. PubMed ID: 17210520
    [Abstract] [Full Text] [Related]

  • 5. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M, Miclea F, Ioiart I, Minciu R, Drăgan P.
    Rom J Morphol Embryol; 1998 Feb; 44(1-4):173-8. PubMed ID: 15678859
    [Abstract] [Full Text] [Related]

  • 6. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM, García Rodríguez J, Escaf Barmadah S, Raigoso P, Rodríguez Martínez JJ, Allende MT, Casasola Chamorro J, Rodríguez Faba O, Martín Benito JL, Regadera Sejas FJ.
    Arch Esp Urol; 2002 Feb; 55(1):41-9. PubMed ID: 11957750
    [Abstract] [Full Text] [Related]

  • 7. Bard BTA test compared with voided urine cytology in the diagnosis of recurrent bladder cancer.
    Leyh H, Mazeman E.
    Eur Urol; 1997 Feb; 32(4):425-8. PubMed ID: 9412800
    [Abstract] [Full Text] [Related]

  • 8. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP, Leppilahti M, Tuhkanen K, Forssel T, Nylund P, Tammela T, FinnBladder Group.
    Ann Chir Gynaecol; 2001 Feb; 90(4):261-5. PubMed ID: 11820414
    [Abstract] [Full Text] [Related]

  • 9. Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study.
    Sullivan PS, Nooraie F, Sanchez H, Hirschowitz S, Levin M, Rao PN, Rao J.
    Cancer; 2009 Jun 25; 117(3):167-73. PubMed ID: 19365828
    [Abstract] [Full Text] [Related]

  • 10. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J, Rodríguez-Martínez JJ, Barmadah SE, García Rodríguez J, Allende DM, Jalon A, Gonzalez R, Alvarez-Múgica M.
    Eur Urol; 2007 May 25; 51(5):1267-74. PubMed ID: 17207912
    [Abstract] [Full Text] [Related]

  • 11. [Value of exfoliative cytology in the diagnosis of bladder tumors].
    Proca E, Lucan M, Popovici D.
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1982 May 25; 31(1):1-7. PubMed ID: 6212969
    [No Abstract] [Full Text] [Related]

  • 12. [Bladder tumor antigen test versus urinary cytology in patients with bladder tumors].
    Gregersen B, Mommsen S, Svanholm H.
    Ugeskr Laeger; 1999 Apr 05; 161(14):2071-3. PubMed ID: 10354792
    [Abstract] [Full Text] [Related]

  • 13. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P, Neulander E, Zirkin H, Yusim I, Douvdevani A, Mermershtain W, Kaneti J, Manor E.
    Urology; 2004 Feb 05; 63(2):398-401. PubMed ID: 14972510
    [Abstract] [Full Text] [Related]

  • 14. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I.
    Cancer; 2007 Dec 25; 111(6):517-24. PubMed ID: 17963263
    [Abstract] [Full Text] [Related]

  • 15. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder.
    Karakiewicz PI, Benayoun S, Zippe C, Lüdecke G, Boman H, Sanchez-Carbayo M, Casella R, Mian C, Friedrich MG, Eissa S, Akaza H, Huland H, Hedelin H, Rupesh R, Miyanaga N, Sagalowsky AI, Marberger MJ, Shariat SF.
    BJU Int; 2006 May 25; 97(5):997-1001. PubMed ID: 16542342
    [Abstract] [Full Text] [Related]

  • 16. [The value of urinary cytology in vesical carcinoma].
    Netto Júnior NR, Hernandez AJ, Lemos GC, França LC.
    AMB Rev Assoc Med Bras; 1981 Jul 25; 27(7):200-2. PubMed ID: 6977152
    [No Abstract] [Full Text] [Related]

  • 17. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?
    Raitanen MP, Aine RA, Kaasinen ES, Liukkonen TJ, Kylmälä TM, Huhtala H, Tammela TL, Finnbladder Group.
    Scand J Urol Nephrol; 2002 Jul 25; 36(3):213-7. PubMed ID: 12201938
    [Abstract] [Full Text] [Related]

  • 18. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
    Moonen PM, Merkx GF, Peelen P, Karthaus HF, Smeets DF, Witjes JA.
    Eur Urol; 2007 May 25; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
    [Abstract] [Full Text] [Related]

  • 19. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug 25; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 20. [The value of cytological examinations in diagnosis of epithelial tumor of bladder].
    Jeromin L, Stapor K.
    Przegl Lek; 1972 Aug 25; 29(2):284-8. PubMed ID: 5018507
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.